Glaucoma Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2024

Thursday, May 24, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, May 23, 2018 /PRNewswire/ --

Glaucoma Therapeutics Market: OverviewGlaucoma is an ocular disease

which affects the optic nerve of the iris and progression of the same results into vision loss and blindness.The treatment for glaucoma starts with topical eye drops belonging to the class of prostaglandins, beta blockers, alpha agonist, combined medication,
carbonic anhydrase inhibitor and cholinergic.Read the full report: https://www.reportlinker.com/p04415276 Administration of these eye drops reduces the production of the fluid inside eyes thereby reducing the intraocular pressure.Using topical eye drops is an alternative for surgery or delays the surgical procedure.This report analyzes the current and future prospects of the glaucoma therapeutics market based on type of drug class, end user and geography.Glaucoma Therapeutics Market: Scope and MethodologyThe research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the major glaucoma therapeutics market in the near future.Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders.Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for each by drug class, end user, and geography for the period 2014 to 2024, considering the macro and micro environmental factors.The revenue generated from each product was calculated by considering number of products used in the procedures and their market demand as per their use, number of product launched, average cost of products of each sub segment, trends in industry, end user trend, and adoption rate across all the geographies. The revenue generated for drug class was calculated on the basis of prevalence of diseases, and number of people affected by the diseaseThe market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market.It also provides information and data analysis of the market with respect to market segments based on drug class, end-user, and geography.The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the glaucoma therapeutics market in the current and future scenario.Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The study also covers detailed country analysis contributing majorly in the glaucoma therapeutics market.Glaucoma Therapeutics Market: Competitive LandscapeMarket share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share.All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market.The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the glaucoma therapeutics market are Allergan Inc., Merck & Co., Pfizer Inc., Novartis AG., Santen Pharmaceuticals, Valeant Pharmaceuticals and Aerie Pharmaceuticals.The glaucoma therapeutics market has been segmented as follows:Glaucoma Therapeutics Market, by Drug ClassAlpha AgonistBeta BlockersProstaglandin AnalogsCarbonic Anhydrase InhibitorCholinergicCombined MedicationGlaucoma Therapeutics Market, by End UsersOphthalmic clinicHospitalsAmbulatory Surgical CentersGlaucoma Therapeutics Market, by GeographyNorth AmericaU.S.CanadaLatin AmericaBrazilMexicoRest of Latin AmericaEuropeU.K.GermanySpainItalyFranceRest of EuropeAsia PacificIndiaJapanChinaAustraliaNew ZealandRest of Asia PacificMiddle East and AfricaSouth AfricaSaudi ArabiaA.E.Rest of MEARead the full report: https://www.reportlinker.com/p04415276 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/glaucoma-therapeutics-market---global-industry-analysis-size-share-volume-growth-trends-and-forecast-2017---2024-300653915.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store